Jia Luo, MD

💫 2024: it's been an incredible year working with the best teams in research and in the clinic at DFCI! Ty #TOPfam for this incredibly meaningful leadership award. Look forward to all that we accomplish in 2025! (🦋 to jia-luo.bsky.social)

Thank you to @Jia_Luo of @DanaFarber for sharing updates at #AACR25 on early ctDNA reduction with daraxonrasib in RAS-mutant NSCLC and new findings from the divarasib + migoprotafib combo in KRAS G12C+ disease. Learn more at OncLive.com. @AACR #lcsm #oncology

KRAS research at #AACR25: Study of next-gen KRAS G12C inhibitor divarasib plus SHP2 inhibition showed activity in treatment of KRAS G12C-positive non-small cell lung cancer (#NSCLC). Patients mostly tolerated the treatment with some dose reductions.

At #AACR25, @Jia_Luo, MD, @DanaFarber presents a late-breaking abstract on the clinical activity of daraxonrasib in KRAS mutant non-small cell lung cancer (#NSCLC), finding early clearance in circulating tumor DNA predicted partial response or stable disease.

✨EXCLUSIVE PREVIEW✨: Ahead of #AACR25, we asked leading oncologists which abstracts they’re looking forward to. @HardingJJMD @Jia_Luo @DrUppaluri @MSKCancerCenter @DanaFarber @MDAndersonNews @AACR #oncology Sign up to access the full preview here:🔗 onclive.com/view/oncology-…

Featured today by @MSKLibrary: Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors dx.doi.org/10.1016/j.anno… #LungCancer #Adenocarcinoma #MucinousHistology #CancerGenomics #TumorMicroenvironment #Immunotherapy #KRASG12C #TargetedTherapy #OncologyResearch #PrecisionMedicine #CancerTreatment #LungCancerAwareness #ImmunoOncology @DiFedericoMD @MLadanyi @ArielleElkrief @rohit_thum @alissajcooper @pecci_federica1 @MaisamMakarem @malini_gandhi @EdoardoGarbo @Arushi03Saini @doctordegio @FavoritoFavors @stescalera @LauraCiprianee @dharadon99 @Jia_Luo

@jennifermarksmd @IASLC Thank you, Dr Marks!

Dr. @Jia_Luo reviews and emphasizes when to suspicious that your patient may have a #NUT carcinomas. We need to ensure that we are using RNA-based NGS testing and/or NUT IHC. #TTLC25 #lcam #lcsm @IASLC

WHAT A WONDERFUL DISCUSSION! Discussing NUT Carcinoma and Mesothelioma with these amazing ladies Dr. @MMarmarelis and @Jia_Luo at #TTLC25 @IASLC

🎙️ LIVE from #TTLC25! @NarjustFlorezMD @Jia_Luo & Dr. Melina Marmarelis discuss two of the most challenging thoracic malignancies—NUT carcinoma & mesothelioma on #LungCancerConsidered. Learn about diagnosis, mutations & targeted therapy. 🎧 Listen now: bit.ly/TTLC24Live1

DFCI Thoracic Oncology Team at #TTLC25! @IASLC @JuliaRotow @sands_jacob @Jia_Luo @NarjustFlorezMD @DavidBarbie8

🔥 @NatRevClinOncol 🆙 ✅Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck 🎯A reclassification of NUT carcinoma as an SCC 👥@Jia_Luo #LCSM @OncoAlert nature.com/articles/s4157…

Lung adenocarcinomas with #mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors - Annals of Oncology annalsofoncology.org/article/S0923-…

New online! Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck nature.com/articles/s4157…

Hiring 🌟 Associate Director 🌟 @ DFCI Center for RAS Therapeutics/ Office of Strategic Partnerships Join a group of brilliant, internationally known investigators who inspire me daily & work @ the cutting edge of drug development careers.dana-farber.org/job/10912/asso… #lcsm #MedTwitter

@PamelaKunzMD Congratulations, Dr Kunz!! You've been an inspiration to me and many others since my SMS days!

I’ve learned resilience, discovered what matters to me, and try to live and lead through my values. As my journey continues, I hope to make a difference. ♥️🙏 6/6

With gratitude and excitement, I am happy to share that I’ve been promoted to Professor of Medicine (Oncology). It's been a long journey since my white coat ceremony. @YaleMed @YaleCancer @ericwiner @royherbst 🧵1/6

We’re thrilled to announce the launch of Center for RAS Therapeutics to target the RAS oncogene in cancer. The first of its kind Center aims to advance new treatment approaches for patients with RAS mutant cancers. Learn more: bit.ly/3BobmtB

A very important slide by @Jia_Luo: Biomarkers are the future, and early detection is the key to transforming outcomes. #PrecisionOncology #EarlyDetection

@rheum_cat @UWRheum Congratulations!!

My mentee matched to my fellowship alma mater @UWRheum 😭 This is so special

Acknowledgements to the 🌟 team at @DFarberThoracic @BrighamWomens Drs French, Shapiro, Hanna, DuBois, Sholl, Barbie, Jänne, & collab Chaft, Paik, Piha-Paul, Hsu, & our patients and funding sources

Fantastic to have✨@jjustinjkim (MD-to-be) and Sara Walton (first poster!)✨present at the 2024 DF/HCC Lung Cancer Program Symposium Ty to the organizing committee for selecting their abstracts